These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparative analysis of two HIV-1 multiepitope polypeptides for stimulation of immune responses in BALB/c mice. Kardani K; Hashemi A; Bolhassani A Mol Immunol; 2020 Mar; 119():106-122. PubMed ID: 32007753 [TBL] [Abstract][Full Text] [Related]
3. In vivo delivery of a multiepitope peptide and Nef protein using novel cell-penetrating peptides for development of HIV-1 vaccine candidate. Davoodi S; Bolhassani A; Namazi F Biotechnol Lett; 2021 Mar; 43(3):547-559. PubMed ID: 33386500 [TBL] [Abstract][Full Text] [Related]
4. Comparison of HIV-1 Vif and Vpu accessory proteins for delivery of polyepitope constructs harboring Nef, Gp160 and P24 using various cell penetrating peptides. Kardani K; Hashemi A; Bolhassani A PLoS One; 2019; 14(10):e0223844. PubMed ID: 31671105 [TBL] [Abstract][Full Text] [Related]
5. Immunopotentiation by linking Hsp70 T-cell epitopes to Gag-Pol-Env-Nef-Rev multiepitope construct and increased IFN-gamma secretion in infected lymphocytes. Akbari E; Ajdary S; Mirabzadeh Ardakani E; Agi E; Milani A; Seyedinkhorasani M; Khalaj V; Bolhassani A Pathog Dis; 2022 Jul; 80(1):. PubMed ID: 35704612 [TBL] [Abstract][Full Text] [Related]
6. Design and in vitro delivery of HIV-1 multi-epitope DNA and peptide constructs using novel cell-penetrating peptides. Davoodi S; Bolhassani A; Sadat SM; Irani S Biotechnol Lett; 2019 Nov; 41(11):1283-1298. PubMed ID: 31531750 [TBL] [Abstract][Full Text] [Related]
7. In silico design and in vitro expression of novel multiepitope DNA constructs based on HIV-1 proteins and Hsp70 T-cell epitopes. Akbari E; Kardani K; Namvar A; Ajdary S; Ardakani EM; Khalaj V; Bolhassani A Biotechnol Lett; 2021 Aug; 43(8):1513-1550. PubMed ID: 33987776 [TBL] [Abstract][Full Text] [Related]
8. Comparison of the Efficacy of HIV-1 Nef-Tat-Gp160-p24 Polyepitope Vaccine Candidate with Nef Protein in Different Immunization Strategies. Namazi F; Davoodi S; Bolhassani A Curr Drug Deliv; 2022; 19(1):142-156. PubMed ID: 33655833 [TBL] [Abstract][Full Text] [Related]
9. In silico designing of novel epitope-based peptide vaccines against HIV-1. Heidarnejad F; Namvar A; Sadat SM; Pordanjani PM; Rezaei F; Namdari H; Arjmand S; Bolhassani A Biotechnol Lett; 2024 Jun; 46(3):315-354. PubMed ID: 38403788 [TBL] [Abstract][Full Text] [Related]
10. Delivery of HIV-1 Polyepitope Constructs Using Cationic and Amphipathic Cell Penetrating Peptides into Mammalian Cells. Namazi F; Bolhassani A; Sadat SM; Irani S Curr HIV Res; 2019; 17(6):408-428. PubMed ID: 31755394 [TBL] [Abstract][Full Text] [Related]
11. Immunological investigation of a multiepitope peptide vaccine candidate based on main proteins of SARS-CoV-2 pathogen. Khairkhah N; Bolhassani A; Agi E; Namvar A; Nikyar A PLoS One; 2022; 17(6):e0268251. PubMed ID: 35679246 [TBL] [Abstract][Full Text] [Related]
12. In Silico Design and Immunologic Evaluation of HIV-1 p24-Nef Fusion Protein to Approach a Therapeutic Vaccine Candidate. Larijani MS; Sadat SM; Bolhassani A; Pouriayevali MH; Bahramali G; Ramezani A Curr HIV Res; 2018; 16(5):322-337. PubMed ID: 30605062 [TBL] [Abstract][Full Text] [Related]
13. Prioritization of potential vaccine candidates and designing a multiepitope-based subunit vaccine against multidrug-resistant Salmonella Typhi str. CT18: A subtractive proteomics and immunoinformatics approach. Chand Y; Singh S Microb Pathog; 2021 Oct; 159():105150. PubMed ID: 34425197 [TBL] [Abstract][Full Text] [Related]
14. Gene and protein delivery using four cell penetrating peptides for HIV-1 vaccine development. Rostami B; Irani S; Bolhassani A; Cohan RA IUBMB Life; 2019 Oct; 71(10):1619-1633. PubMed ID: 31220406 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of transduced dendritic cells expressing HIV-1 p24-Nef antigens in HIV-specific cytotoxic T cells induction as a therapeutic candidate vaccine. Sadat Larijani M; Ramezani A; Mashhadi Abolghasem Shirazi M; Bolhassani A; Pouriayevali MH; Shahbazi S; Sadat SM Virus Res; 2021 Jun; 298():198403. PubMed ID: 33775753 [TBL] [Abstract][Full Text] [Related]
16. Induction of human immunodeficiency virus type-1-specific immunity with a novel gene transport unit (GTU)-MultiHIV DNA vaccine. Blazevic V; Männik A; Malm M; Sikut R; Valtavaara M; Toots U; Ustav M; Krohn K AIDS Res Hum Retroviruses; 2006 Jul; 22(7):667-77. PubMed ID: 16831091 [TBL] [Abstract][Full Text] [Related]
17. B1 protein: a novel cell penetrating protein for in vitro and in vivo delivery of HIV-1 multi-epitope DNA constructs. Kardani K; Bolhassani A; Agi E; Hashemi A Biotechnol Lett; 2020 Oct; 42(10):1847-1863. PubMed ID: 32449070 [TBL] [Abstract][Full Text] [Related]
18. Optimization and immune recognition of multiple novel conserved HLA-A2, human immunodeficiency virus type 1-specific CTL epitopes. Corbet S; Nielsen HV; Vinner L; Lauemoller S; Therrien D; Tang S; Kronborg G; Mathiesen L; Chaplin P; Brunak S; Buus S; Fomsgaard A J Gen Virol; 2003 Sep; 84(Pt 9):2409-2421. PubMed ID: 12917462 [TBL] [Abstract][Full Text] [Related]
19. Prediction of cross-clade HIV-1 T-cell epitopes using immunoinformatics analysis. Khairkhah N; Namvar A; Kardani K; Bolhassani A Proteins; 2018 Dec; 86(12):1284-1293. PubMed ID: 30260061 [TBL] [Abstract][Full Text] [Related]
20. Combination of cell penetrating peptides and heterologous DNA prime/protein boost strategy enhances immune responses against HIV-1 Nef antigen in BALB/c mouse model. Kadkhodayan S; Jafarzade BS; Sadat SM; Motevalli F; Agi E; Bolhassani A Immunol Lett; 2017 Aug; 188():38-45. PubMed ID: 28602843 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]